Bicocca Open Archive

Logo unimib boa
L'IMPERIO, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.978
AS - Asia 11.770
EU - Europa 9.187
SA - Sud America 1.636
Continente sconosciuto - Info sul continente non disponibili 770
AF - Africa 283
OC - Oceania 40
Totale 41.664
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.084
IT - Italia 4.153
SG - Singapore 4.153
VN - Vietnam 2.152
CN - Cina 2.139
HK - Hong Kong 1.239
BR - Brasile 1.178
RU - Federazione Russa 1.008
DE - Germania 885
SE - Svezia 641
CA - Canada 611
BD - Bangladesh 564
IE - Irlanda 480
FR - Francia 408
GB - Regno Unito 384
IN - India 327
KR - Corea 218
NL - Olanda 176
ID - Indonesia 171
AT - Austria 169
FI - Finlandia 165
AR - Argentina 142
UA - Ucraina 135
MX - Messico 121
TR - Turchia 116
ES - Italia 112
IQ - Iraq 109
ZA - Sudafrica 96
JP - Giappone 93
PL - Polonia 87
PK - Pakistan 86
CH - Svizzera 78
DK - Danimarca 76
PH - Filippine 71
EC - Ecuador 70
VE - Venezuela 65
CO - Colombia 64
SA - Arabia Saudita 53
AU - Australia 38
UZ - Uzbekistan 38
CR - Costa Rica 37
JM - Giamaica 33
LT - Lituania 33
BE - Belgio 32
CL - Cile 32
TN - Tunisia 32
MA - Marocco 29
MY - Malesia 28
AE - Emirati Arabi Uniti 27
PY - Paraguay 27
GR - Grecia 24
UY - Uruguay 24
EG - Egitto 23
JO - Giordania 23
PE - Perù 23
PT - Portogallo 21
ET - Etiopia 19
NP - Nepal 18
DZ - Algeria 16
KE - Kenya 15
AZ - Azerbaigian 13
EE - Estonia 13
KZ - Kazakistan 13
TH - Thailandia 13
TT - Trinidad e Tobago 13
TW - Taiwan 13
CZ - Repubblica Ceca 12
DO - Repubblica Dominicana 12
IL - Israele 12
AL - Albania 11
BY - Bielorussia 11
LB - Libano 11
NI - Nicaragua 11
OM - Oman 11
HN - Honduras 10
IR - Iran 10
RO - Romania 10
RS - Serbia 10
PA - Panama 9
SC - Seychelles 9
SV - El Salvador 9
BO - Bolivia 8
HU - Ungheria 8
AO - Angola 7
GT - Guatemala 7
KG - Kirghizistan 7
LV - Lettonia 7
PS - Palestinian Territory 7
SI - Slovenia 7
SY - Repubblica araba siriana 7
NO - Norvegia 6
SN - Senegal 6
AM - Armenia 5
BG - Bulgaria 5
MD - Moldavia 5
MN - Mongolia 5
NG - Nigeria 5
SK - Slovacchia (Repubblica Slovacca) 5
BB - Barbados 4
LY - Libia 4
Totale 40.822
Salva come PNG Salva come JPEG
Città #
Singapore 2.296
Ashburn 2.093
San Jose 1.863
Ann Arbor 1.479
Milan 1.325
Hong Kong 1.194
Ho Chi Minh City 661
Hanoi 549
Los Angeles 547
Dallas 537
Frankfurt am Main 532
New York 496
Dublin 460
Santa Clara 444
Hefei 418
Council Bluffs 417
Fairfield 389
Toronto 352
Chandler 347
Wilmington 295
Rome 288
Chicago 285
Beijing 273
Houston 256
Woodbridge 221
Phoenix 205
The Dalles 204
Seattle 196
Seoul 192
Buffalo 185
Columbus 164
Princeton 150
Lauterbourg 144
Boardman 143
São Paulo 136
Dearborn 133
Cambridge 115
Jakarta 109
Shanghai 107
Vienna 107
Moscow 97
Da Nang 93
Montreal 90
Orem 89
Helsinki 88
Jacksonville 88
Denver 84
Munich 84
London 82
Turin 76
Naples 75
Warsaw 73
Atlanta 72
Tokyo 69
Brooklyn 67
Haiphong 64
Nanjing 61
Nuremberg 61
Kent 56
Chennai 55
Dong Ket 54
Figino 54
Altamura 53
Bologna 53
Johannesburg 51
Lawrence 51
Philadelphia 51
Washington 51
Florence 50
Lissone 49
Guangzhou 48
Boston 43
Ha Long 43
Sesto San Giovanni 43
Baghdad 42
Hải Dương 42
Salt Lake City 41
Newark 40
Stockholm 39
Zurich 39
Busto Arsizio 38
Monza 38
Lappeenranta 37
Manchester 37
Mexico City 36
Poplar 36
Tashkent 35
Dhaka 34
Istanbul 34
Rio de Janeiro 34
Amsterdam 33
Thái Nguyên 32
Bari 31
Biên Hòa 31
San José 31
Brasília 30
Bắc Ninh 30
Can Tho 30
New Delhi 30
Quito 30
Totale 23.435
Salva come PNG Salva come JPEG
Nome #
Destructuring glomerular diseases with structured deposits: challenges in the precision medicine era 607
The putative role of MALDI-MSI in the study of Membranous Nephropathy 457
Rendering the invisible visible: adding a molecular dimension to pathology with spatial omics 454
Sequential MALDI-HiPLEX-IHC and Untargeted Spatial Proteomics Mass Spectrometry Imaging to Detect Proteomic Alterations Associated with Tumour Infiltrating Lymphocytes 428
The proteomic landscape of renal tumors 428
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 425
MiralysTM Ambergen. Sequential MALDI-HiPLEX-IHC and untargeted protein imaging to map the tumour-immune environment: academic researcher experience 424
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 419
MALDI imaging in Fabry nephropathy: a multicenter study 417
Picture this: Mass Spectrometry Imaging to unveil the multiomic layers of the tumor immune environment 409
Analysis of Hashimoto's thyroiditis on fine needle aspiration samples by MALDI-Imaging 405
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 400
Kidney Involvement 399
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 399
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 397
Remission of low-grade lymphomatoid granulomatosis with extensive pulmonary involvement following immune restoration via antiretroviral therapy in a newly diagnosed HIV patient 387
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 387
PD-L1 Testing and Squamous Cell Carcinoma of the Head and Neck: A Multicenter Study on the Diagnostic Reproducibility of Different Protocols 384
Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies 382
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 370
Cytopathology of Bronchoalveolar Lavages in COVID-19 Pneumonia: A Pilot Study 365
Proteomics for the study of new biomarkers in Fabry disease: State of the art 363
Proteome analysis in thyroid pathology 357
"Pathologists in Venice - Real World Cases for an Immersive Training Experience": Education, Gaming, and Show 355
Digital counting of tissue cells for molecular analysis: the QuANTUM pipeline 354
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 350
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 350
Deep learning helps discriminate between autoimmune hepatitis and primary biliary cholangitis 346
Machine learning streamlines the morphometric characterization and multi-class segmentation of nuclei in different follicular thyroid lesions: everything in a NUTSHELL 345
Cytomolecular Classification of Thyroid Nodules Using Fine-Needle Washes Aspiration Biopsies 344
Use of diagnostic criteria from acr and eu-tirads systems to improve the performance of cytology in thyroid nodule triage 343
Diagnostic performances of the acr-tirads system in thyroid nodules triage: A prospective single center study 339
Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity 337
Granulomatosis with polyangiitis presenting with diffuse alveolar hemorrhage requiring extracorporeal membrane oxygenation with rapid multiorgan relapse: A case report 334
Benchmarking digital displays (monitors) for histological diagnoses: the nephropathology use case 332
Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs) 304
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology 303
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 301
Debating the pros and cons of computational pathology at the European Congress of Pathology (ECP) 2024 300
Improvements in digital pathology equipment for renal biopsies: updating the standard model 298
Clinicopathological characteristics of typical and atypical anti-glomerular basement membrane nephritis 298
Dissecting the histological features of lupus nephritis highlights new common patterns of injury in class III/IV 294
Enhancing proteomics characterization of thyroid nodules: a pixel-classifier for mass spectrometry imaging analyses 294
Pathology Laboratory Archives: Conservation Quality of Nucleic Acids and Proteins for NSCLC Molecular Testing 287
Lipids, proteins, cells: advanced spatial multiomics to delve deeper into the complex molecular and cellular landscape of the tumour microenvironment 285
Improving the Annotation Process in Computational Pathology: A Pilot Study with Manual and Semi-automated Approaches on Consumer and Medical Grade Devices 285
Digital twin manifesto for the pathology laboratory 283
Nodal monoclonal CD5-positive B-lymphocytosis and toxoplasma lymphadenitis: Another variant in the spectrum of infectious lymphadenitis in patients with chronic leukemia/small lymphocytic lymphoma 282
The therapeutic potential of an allosteric non-competitive CXCR1/2 antagonist for diabetic nephropathy 277
Immunosuppression in idiopathic membranous nephropathy: A double-edge sword 277
The Complex Cyto-Molecular Landscape of Thyroid Nodules in Pediatrics 275
Goodpasture syndrome and anti-glomerular basement membrane disease 275
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 272
6-Aza-2-Thiothymine as an Alternative Matrix for Spatial Proteomics with MALDI-MSI 268
MALDI-MS imaging in the study of glomerulonephritis 267
Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions 266
An Indeterminate for Malignancy FNA Report Does Not Increase the Surgical Risk of Incidental Thyroid Carcinoma 263
More than an ‘atypical’ phenotype: dual molecular diagnosis of autoimmune lymphoproliferative syndrome and Becker muscular dystrophy 262
Digital transition in pathology lab: a survey from the Lombardy region 260
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 259
The routine use of a digital tool for the tumor cell fraction quantification in molecular pathology: an international validation of QuANTUM 256
Displaced Cartilage Within Lymph Node Parenchyma Is a Novel Biopsy Site Change in Resected Mediastinal Lymph Nodes Following EBUS-TBNA 255
The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome 253
Congo Red Staining in Digital Pathology: The Streamlined Pipeline for Amyloid Detection Through Congo Red Fluorescence Digital Analysis 251
Anticoagulant-related nephropathy: a pathological note 251
Automate the process of formalin-fixed paraffin-embedded blocks storage in the pathology laboratory: A proof of concept study 248
Renal involvement in eosinophilic granulomatosis with polyangiitis 247
Systemic vasculitis involving the kidney: the nephropathologist's point of view 245
Biomarker identification through spatial proteomics for the characterization of indeterminate thyroid nodules 245
A Mass Spectrometry Imaging-based multiomics approach to map the tumour-immune landscape of clear cell Renal Cell Carcinoma and gain insights into resistance to immunotherapy 245
Tumour incidence in Fabry disease: A cross-sectional study 243
Monoclonal Gammopathy of Renal Significance: A Molecular Middle Earth between Oncology, Nephrology, and Pathology 242
Bone Marrow CD8 + Abundance Inversely Correlates with Progressive Marrow Fibrosis and Myelodysplastic Evolution in GATA2 Deficiency: Case Report 241
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 238
The role of digital and integrative pathology for the detection of translocations: a narrative review 237
Economic assessment of NGS testing workflow for NSCLC in a healthcare setting 237
Different clusters in patients with lupus podocytopathy identified by clinical-pathological characteristics 237
Digital pathology for the routine diagnosis of renal diseases: a standard model 237
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? 235
Monoclonal gammopathy of renal significance: Systemic involvement by benign condition 235
Kidney Function, CKD Causes, and Histological Classification 235
Galileo—an Artificial Intelligence tool for evaluating pre-implantation kidney biopsies 233
Digital Pathology Applications for PD-L1 Scoring in Head and Neck Squamous Cell Carcinoma: A Challenging Series 232
Un nuovo approccio basato sull’Imaging con Spettrometria di Massa per la sottotipizzazione dell’amiloidosi renale [A novel mass spectrometry imaging based approach for the subtyping of renal amyloidosisn] 230
#EBUSTwitter: Novel use of social media for conception, coordination, and completion of an international, multicenter pathology study 224
Single-slide detection and typing of AL renal amyloidosis: combining mass spectrometry imaging and digital pathology 223
Congo red fluorescence enhances digital pathology workflow in cardiac amyloidosis 223
Artificial intelligence–based algorithms for the diagnosis of prostate cancer: A systematic review 222
The putative role of MALDI-MSI in the study of Membranous Nephropathy 221
Changing Phenotypes and Clinical Outcomes Over Time in Microscopic Polyangiitis 220
Pathologist Validation of a Machine Learning-Derived Feature for Colon Cancer Risk Stratification 218
JAK2-mutated Langerhans cell histiocytosis associated with primary myelofibrosis treated with ruxolitinib 218
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 215
The putative role of MALDI-MSI in the study of Membranous Nephropathy 213
The Puzzle of Preimplantation Kidney Biopsy Decision-Making Process: The Pathologist Perspective 211
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 211
MALDI-MS Imaging in Membranous Nephropathy: from the research to the clinical laboratory? 210
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 210
Machine Learning for Monoclonal Gammopathies of Renal Significance Risk Stratification Using Clinical and Pathology Data 209
Imaging molecolare a livello cellulare: possiamo predire la risposta alla terapia nella Nefropatia Membranosa? 207
Totale 29.890
Salva come PNG Salva come JPEG
Categoria #
all - tutte 126.166
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.166
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022786 0 0 0 68 68 101 26 79 33 83 123 205
2022/20231.928 185 503 193 146 106 275 53 144 164 41 81 37
2023/20241.950 67 85 86 121 190 442 351 70 175 40 87 236
2024/20256.832 234 517 624 277 469 287 329 219 645 1.000 884 1.347
2025/202619.937 2.259 1.479 1.468 2.059 1.886 853 2.698 820 1.318 1.806 1.584 1.707
2026/20275.788 1.012 1.206 2.288 1.282 0 0 0 0 0 0 0 0
Totale 41.664